Immunotherapy for musculoskeletal system diseases

Joint and back pain is usually treated with painkillers and anti-inflammatories, and in severe cases surgery is offered. Regenerative hemoimmunotherapy looks for a middle path: reduce inflammation and support tissue recovery to bring pain under control without surgery.

The method is based on the patient's own cells. From the blood we prepare components that reduce inflammation in the joint or spinal tissues and create conditions for their recovery. Nothing foreign is introduced.

The approach is used in osteoarthritis, after joint injuries, and in spinal diseases - osteochondrosis, dorsopathy, and disc protrusions. It is especially relevant in early and moderate stages and as a way to postpone or ease the need for surgery.

The physician decides whether treatment is possible and how it is structured after assessing the joint or spine on imaging and the treatment history. The method combines with therapeutic exercise and is gently tolerated.

It is worth saying plainly where the method ends. Regenerative therapy works on inflammation and on the state of the tissue, but it does not bring back cartilage that is gone. In stage III–IV osteoarthritis, where the joint space has all but disappeared and bone meets bone, the only solution giving a durable result is joint replacement. In that situation we say so and do not offer a course.

At early and moderate stages the picture is different. The main enemy there is a vicious circle: inflammation destroys cartilage, cartilage breakdown products sustain inflammation, pain makes you spare the joint, reduced load weakens the muscles, and weak muscles overload the joint further. The method aims to break that circle at its most vulnerable point — the inflammation.

With the spine the logic is similar but with a caveat. Back pain more often comes not from the disc protrusion itself but from inflammation of the surrounding tissue and muscle spasm — which is why the size of a herniation on MRI correlates poorly with the severity of pain. The goal is therefore put differently: reduce inflammation and restore mobility, rather than remove the herniation. Absolute indications for surgery — increasing leg weakness, bladder or bowel dysfunction, cauda equina syndrome — remain indications for surgery, and those cases need a neurosurgeon, not immunotherapy.

The result here depends on the patient more than in other areas. Without exercise therapy and weight control, the effect of any joint procedure is shorter than it could be: every extra kilogram of body weight is multiplied several times over as load on the knee during walking. That is why a course always comes with movement recommendations, and that is part of the treatment, not a formality.